EUR 25.05
(0.2%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 98.83 Million EUR | 2.59% |
2022 | 32.28 Million EUR | -1.6% |
2021 | 85.09 Million EUR | -2.0% |
2020 | 79.2 Million EUR | -15.28% |
2019 | 111.63 Million EUR | 6.53% |
2018 | 104.84 Million EUR | -10.19% |
2017 | 116.74 Million EUR | 16.52% |
2016 | 103.14 Million EUR | 17.21% |
2015 | 85.48 Million EUR | 37.05% |
2014 | 62.48 Million EUR | 26.31% |
2013 | 51.4 Million EUR | -10.86% |
2012 | 51.88 Million EUR | 30.23% |
2011 | 42.6 Million EUR | 26.66% |
2010 | 27.88 Million EUR | -30.72% |
2009 | 47.91 Million EUR | -14.03% |
2008 | 56.46 Million EUR | 7.77% |
2007 | 51.33 Million EUR | 20.87% |
2006 | 43.1 Million EUR | -16.49% |
2005 | 51.72 Million EUR | 15.07% |
2004 | 45.04 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 60.41 Million EUR | 0.0% |
2023 FY | - EUR | 2.59% |
2023 Q2 | 40.64 Million EUR | 0.0% |
2023 Q4 | 49.74 Million EUR | 0.0% |
2022 FY | - EUR | -1.6% |
2022 Q4 | 48.77 Million EUR | 0.0% |
2022 Q2 | 43.12 Million EUR | 0.0% |
2021 Q4 | 32.28 Million EUR | 0.0% |
2021 Q2 | 61.54 Million EUR | 0.0% |
2021 FY | - EUR | -2.0% |
2020 Q4 | 43.03 Million EUR | 0.0% |
2020 Q2 | 52.08 Million EUR | 0.0% |
2020 FY | - EUR | -15.28% |
2019 Q4 | 58.62 Million EUR | 0.0% |
2019 Q2 | 51.84 Million EUR | 0.0% |
2019 FY | - EUR | 6.53% |
2018 Q4 | 47.19 Million EUR | 0.0% |
2018 Q2 | 57.65 Million EUR | 0.0% |
2018 FY | - EUR | -10.19% |
2017 FY | - EUR | 16.52% |
2017 Q2 | 61.48 Million EUR | 0.0% |
2017 Q4 | 55.26 Million EUR | 0.0% |
2016 FY | - EUR | 17.21% |
2016 Q2 | 50.63 Million EUR | 0.0% |
2016 Q4 | 49.56 Million EUR | 0.0% |
2015 Q4 | 43.02 Million EUR | 0.0% |
2015 Q2 | 42.45 Million EUR | 0.0% |
2015 FY | - EUR | 37.05% |
2014 FY | - EUR | 26.31% |
2014 Q4 | 31.45 Million EUR | 0.0% |
2014 Q2 | 30.92 Million EUR | 0.0% |
2013 Q2 | 26.04 Million EUR | 0.0% |
2013 Q4 | 23.34 Million EUR | 0.0% |
2013 FY | - EUR | -10.86% |
2012 Q1 | 12.96 Million EUR | 0.0% |
2012 FY | - EUR | 30.23% |
2012 Q4 | 13.15 Million EUR | 1.48% |
2012 Q3 | 12.96 Million EUR | 0.0% |
2012 Q2 | 12.96 Million EUR | 0.0% |
2011 FY | - EUR | 26.66% |
2011 Q3 | 10.63 Million EUR | 0.0% |
2011 Q1 | 10.63 Million EUR | 0.0% |
2011 Q2 | 10.63 Million EUR | 0.0% |
2011 Q4 | 12.96 Million EUR | 21.93% |
2010 Q1 | 6.97 Million EUR | 0.0% |
2010 Q3 | 6.97 Million EUR | 0.0% |
2010 FY | - EUR | -30.72% |
2010 Q4 | 10.63 Million EUR | 52.58% |
2010 Q2 | 6.97 Million EUR | 0.0% |
2009 Q3 | 12.11 Million EUR | 0.0% |
2009 Q1 | 12.11 Million EUR | 0.0% |
2009 FY | - EUR | -14.03% |
2009 Q4 | 6.97 Million EUR | -42.48% |
2009 Q2 | 12.11 Million EUR | 0.0% |
2008 Q3 | 14.09 Million EUR | 0.0% |
2008 Q2 | 14.09 Million EUR | 0.0% |
2008 Q1 | 14.09 Million EUR | 0.0% |
2008 FY | - EUR | 7.77% |
2008 Q4 | 12.11 Million EUR | -14.04% |
2007 Q4 | 14.09 Million EUR | 7.77% |
2007 Q3 | 13.08 Million EUR | 0.0% |
2007 Q2 | 13.08 Million EUR | 0.0% |
2007 Q1 | 13.08 Million EUR | 0.0% |
2007 FY | - EUR | 20.87% |
2006 Q1 | 10.85 Million EUR | 0.0% |
2006 FY | - EUR | -16.49% |
2006 Q3 | 10.85 Million EUR | 0.0% |
2006 Q2 | 10.85 Million EUR | 0.0% |
2006 Q4 | 13.08 Million EUR | 20.47% |
2005 Q1 | 12.93 Million EUR | 0.0% |
2005 Q4 | 10.85 Million EUR | -16.03% |
2005 Q3 | 12.93 Million EUR | 0.0% |
2005 Q2 | 12.93 Million EUR | 0.0% |
2005 FY | - EUR | 15.07% |
2004 FY | - EUR | 0.0% |
2004 Q2 | 10.94 Million EUR | 0.0% |
2004 Q1 | 10.94 Million EUR | 0.0% |
2004 Q3 | 10.94 Million EUR | 0.0% |
2004 Q4 | 12.93 Million EUR | 18.19% |
2003 Q4 | 10.94 Million EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Affluent Medical SA | -13.34 Million EUR | 840.755% |
Bluelinea Société Anonyme | -323.98 EUR | 30507847.392% |
Carmat SA | -50.45 Million EUR | 295.907% |
Diagnostic Medical Systems S.A. | -7.05 Million EUR | 1500.581% |
Euromedis Groupe | -4.43 Million EUR | 2328.518% |
Eurobio Scientific Société anonyme | 18.98 Million EUR | -420.589% |
Ikonisys S.A. | -2.34 Million EUR | 4310.347% |
Implanet S.A. | -5.07 Million EUR | 2046.799% |
Median Technologies SA | -19.58 Million EUR | 604.667% |
SpineGuard SA | -3.49 Million EUR | 2926.54% |
Theraclion SA | -4.48 Million EUR | 2302.668% |
Euroapi S.A. | -155.39 Million EUR | 163.603% |
Ion Beam Applications SA | 12.53 Million EUR | -688.819% |
Koninklijke Philips N.V. | 1.04 Billion EUR | 90.505% |
Sequana Medical NV | -29.13 Million EUR | 439.224% |